Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03134092 · ClinicalTrials.gov registry record · NA
The Life STORRIED Study
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,302
- Enrollment target
NCT03134092: Completed NA study, sponsored by University of Pennsylvania.
NCT03134092 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,302 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03134092, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,302 participants
- Enrollment target
Study Summary
To compare the effectiveness of 3 strategies to inform patients of their risks associated with misuse of opioid prescriptions after treatment in the ED from renal colic or musculoskeletal back pain. Randomization will be to 3 arms for the Randomized Practical Control Trial across 3 sites (A) standardized general risk information sheet only (B) standardized general risk information sheet plus a visual probabilistic risk tool (C) standardized sheet plus narrative enhanced probabilistic risk tool.
Interventions
- OTHER Probabilistic Risk Communication Tool (PRT)
- OTHER Narrative Enhanced Risk Tool (NERT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,302 participants |
| Start Date | 2017-06-28 |
| Est. Completion | 2019-11-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03134092
The ClinicalTrials.gov registry entry for NCT03134092 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,302 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Probabilistic Risk Communication Tool (PRT) is the first listed.
NCT03134092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03134092 about?
NCT03134092 is a clinical study titled "The Life STORRIED Study". To compare the effectiveness of 3 strategies to inform patients of their risks associated with misuse of opioid prescriptions after treatment in the ED from renal colic or musculoskeletal back pain. Randomization will be to 3 arms for the Randomized Practical Control Trial across 3 sites (A) standar...
What is the current status of trial NCT03134092?
This trial is currently completed. It is a NA study. The enrollment target is 1,302 participants. The study started on 2017-06-28. Estimated completion is 2019-11-19.
What interventions are being tested in trial NCT03134092?
The interventions under investigation include: Probabilistic Risk Communication Tool (PRT) (OTHER), Narrative Enhanced Risk Tool (NERT) (OTHER).
Who is sponsoring clinical trial NCT03134092?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.